Modulo Bio

About:

Modulo Bio is a biotech company that offers a platform for reprogramming neurocells to improve immunity.

Twitter/X: ModuloBio

Top Investors: Builders VC, Initialized Capital, Refactor, Cantos, Spacecadet Ventures

Description:

Modulo Bio simulates the neuroimmune system to find medication candidates that target microglia cells. The organization's proprietary neuroimmune platform combines the most recent developments in stem cell biology and neuroscience with software, automation, and artificial intelligence to create novel treatments.

Total Funding Amount:

$17.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2020-01-01

Contact Email:

hello(AT)modulo.bio

Founders:

Justin Ichida, Mike Horowitz, Scott Patterson

Number of Employees:

1-10

Last Funding Date:

2024-11-20

IPO Status:

Private

Industries: